ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-02204
製品名称
LBP Protein, Human, Recombinant (His)
タンパク質名
LBP
Species
Human
HOST
HEK293 Cells
50μg: -
お問い合わせ

Overview

Synonyms BPIFD2, lipopolysaccharide binding protein
Characteristics Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity 98.40%
Description Lipopolysaccharide binding protein ( LBP ) is a glycoprotein that is synthesized principally by hepatocytes. LBP is a trace plasma protein that binds to the lipid A moiety of bacterial lipopolysaccharides ( LPSs ). LBP binds directly to the outer membrane of Gram-negative bacteria and purified aggregates of extracted endotoxin and catalyzes the delivery of endotoxin to the membrane ( mCD14, GPI-Linked ) and soluble ( sCD14 ) forms of CD14, thereby markedly increasing host cell sensitivity to endotoxin. LBP efficiently catalyzes the transfer of individual molecules of endotoxin to (s)CD14 only when LBP?endotoxin aggregates are formed in the presence of albumin. In the presence of EDTA, LBP binding promotes further disaggregation of endotoxin. LBP binding does not have such drastic effects under more physiological conditions, but may still induce more subtle topological rearrangements of endotoxin.
Reference Carsten J. Kirschning, et al., 1997, Genomics, Volume 46, Issue 3: 416-25.,J. Weiss, 2003, Biochemical Society Transactions: Volume 31, part 4: 785-790.,RR Schumann, et al., Science, 1990, Vol 249, Issue 4975: 1429-143.
URL https://www.targetmol.com/recombinant-protein/lbp_protein_human_recombinant_his_tag_

お問い合わせリスト(-)

お問い合わせフォーム